| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 33.372 | 37.350 | 27.561 | 29.024 | 24.749 | 29.194 | 39.302 | 44.542 | 41.345 | 44.334 |
| Total Income - EUR | 33.372 | 37.404 | 27.561 | 29.024 | 24.866 | 29.209 | 39.306 | 44.795 | 41.345 | 45.765 |
| Total Expenses - EUR | 25.426 | 19.408 | 15.607 | 10.807 | 17.557 | 14.758 | 13.547 | 17.507 | 32.900 | 30.140 |
| Gross Profit/Loss - EUR | 7.946 | 17.996 | 11.954 | 18.217 | 7.309 | 14.451 | 25.759 | 27.289 | 8.445 | 15.625 |
| Net Profit/Loss - EUR | 6.945 | 17.248 | 11.678 | 17.927 | 7.077 | 14.233 | 25.444 | 26.939 | 6.739 | 12.747 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Profintermed Asig Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.721 | 1.759 | 884 | 1.203 | 17.569 | 13.548 | 9.968 | 6.753 | 4.242 | 562 |
| Current Assets | 5.832 | 16.656 | 11.868 | 17.304 | 2.036 | 9.437 | 19.510 | 24.297 | 4.040 | 14.793 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 2.364 | 0 | 8.528 | 13.140 | 20.274 | 115 | 0 |
| Cash | 5.832 | 16.656 | 11.868 | 14.941 | 2.036 | 909 | 6.371 | 4.023 | 3.925 | 14.793 |
| Shareholders Funds | 7.001 | 17.304 | 11.733 | 17.981 | 7.130 | 16.060 | 25.495 | 26.990 | 6.789 | 12.798 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 1.552 | 1.110 | 1.018 | 526 | 12.475 | 6.926 | 3.983 | 4.060 | 1.541 | 2.629 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6622 - 6622" | |||||||||
| CAEN Financial Year |
6622
|
|||||||||
Comments - Profintermed Asig Srl